Arvind Remedies Ltd.
|
Company Meetings
|
|
You can view the entire list of various company locations such as Registered office,
Plants, etc with detail
Market Cap. (Rs.)
|
-
|
P/BV
|
-
|
Book Value (Rs.)
|
-
|
52 Week High/Low (Rs.)
|
-
|
FV/ML
|
-
|
P/E(X)
|
-
|
Bookclosure
|
-
|
EPS (Rs.)
|
-
|
Div Yield (%)
|
-
|
|
Date of Meeting | Purpose |
12/08/2016 | Quarterly Results & Others |
24/03/2016 | Quarterly Results |
21/03/2016 | Others |
17/02/2016 | Quarterly Results |
26/11/2015 | Quarterly Results |
11/07/2015 | Others |
28/05/2015 | Audited Results & Issue of Shares |
27/02/2015 | Quarterly Results |
13/11/2014 | Quarterly Results |
09/08/2014 | Quarterly Results |
Annt. Date | Purpose | Book Closure Start | Book Closure End | Remarks |
22/03/2016 | AGM | 15/04/2016 | 18/04/2016 | - |
11/08/2014 | AGM | 26/09/2014 | 29/09/2014 | Rs.0.8000 per share(8%)Dividend |
03/06/2013 | AGM | 19/09/2013 | 23/09/2013 | Rs.0.2000 per share(2%)Special Dividend & Rs.0.8000 per share(8%)Dividend |
11/06/2012 | AGM | 11/09/2012 | 14/09/2012 | Rs.0.70 per share(7%)Dividend (Revised) |
12/04/2012 | EGM | - | - | To transact the following: 1. Consolidation of Equity Shares from Re. 1/- each to Rs. 10/- each. 2. Issue of Equity Warrants. 3. Increase in Authorised Share Capital. |
13/02/2012 | EGM | - | - | For funding of the separate Betalactum, Cephalosporin & Ayurvedic units which are in pipeline, at cost of Rs.190 Crs, Rs.140 Crs by term loan and balace Rs.50 Crs by way of Equity Shares on preferential bais. |
18/10/2011 | EGM | - | - | - |
02/06/2011 | AGM | 16/09/2011 | 19/09/2011 | Rs.0.07 per share(7%)Dividend |
01/09/2010 | AGM | 25/09/2010 | 28/09/2010 | Rs.0.05 per share(5%)Dividend |